Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Parkinson's Disease market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Parkinson's Disease market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Parkinson's Disease market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Parkinson's Disease products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Parkinson's Disease products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Parkinson's Disease market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Parkinson's Disease development has been the leading industry trend of Parkinson's Disease market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Parkinson's Disease Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Drug Class Outlook |
Levodopa/Carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-Inhibitors, Anticholinergics, Other Drugs |
| By Distribution Channel Outlook |
Hospital Pharmacies, Clinics, Retail Pharmacies, Online Pharmacies |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Teva, Novartis, GSK, AbbVie, Merck, Boehringer Ingelheim, Impax, Lundbeck, Sun Pharma, Wockhardt, UCB, Valeant Pharmaceuticals, Acadia |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Teva
- Novartis
- GSK
- AbbVie
- Merck
- Boehringer Ingelheim
- Impax
- Lundbeck
- Sun Pharma
- Wockhardt
- UCB
- Valeant Pharmaceuticals
- Acadia
Parkinson's Disease Market, By Drug Class
- Levodopa/Carbidopa
- Dopamine Receptor Agonists
- MAO-Inhibitors
- COMT-Inhibitors
- Anticholinergics
- Other
Parkinson's Disease Market, By Medical Devices
- Deep Brain Stimulation (DBS) Devices
- Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices
Parkinson's Disease Market, By Route of Administration
- Oral
- Transdermal
- Subcutaneous
- Intestinal Infusion
- Others
Parkinson's Disease Market, By Distribution Channel
- Hospital Pharmacies
- Clinics
- Retail Pharmacies
- Online Pharmacies
Parkinson's Disease Market, By Patient Care Setting
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Parkinson's Disease Market Overview
1.1 Parkinson's Disease Product Overview
1.2 Parkinson's Disease Market Segment by Type
1.2.1 Carbidopa/Levodopa
1.2.2 Dopamine Receptor Agonists
1.2.3 MAO-Inhibitors
1.3 Global Parkinson's Disease Market Size by Type
1.3.1 Global Parkinson's Disease Sales and Growth by Type
1.3.2 Global Parkinson's Disease Sales and Market Share by Type (2014-2019)
1.3.3 Global Parkinson's Disease Revenue and Market Share by Type (2014-2019)
1.3.4 Global Parkinson's Disease Price by Type (2014-2019)
2 Global Parkinson's Disease Market Competition by Company
2.1 Global Parkinson's Disease Sales and Market Share by Company (2014-2019)
2.2 Global Parkinson's Disease Revenue and Share by Company (2014-2019)
2.3 Global Parkinson's Disease Price by Company (2014-2019)
2.4 Global Top Players Parkinson's Disease Manufacturing Base Distribution, Sales Area, Product Types
2.5 Parkinson's Disease Market Competitive Situation and Trends
2.5.1 Parkinson's Disease Market Concentration Rate
2.5.2 Global Parkinson's Disease Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Parkinson's Disease Company Profiles and Sales Data
3.1 Teva
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Parkinson's Disease Product Category, Application and Specification
3.1.3 Teva Parkinson's Disease Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Novartis
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Parkinson's Disease Product Category, Application and Specification
3.2.3 Novartis Parkinson's Disease Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 GSK
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Parkinson's Disease Product Category, Application and Specification
3.3.3 GSK Parkinson's Disease Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 AbbVie
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Parkinson's Disease Product Category, Application and Specification
3.4.3 AbbVie Parkinson's Disease Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Merck
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Parkinson's Disease Product Category, Application and Specification
3.5.3 Merck Parkinson's Disease Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Boehringer Ingelheim
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Parkinson's Disease Product Category, Application and Specification
3.6.3 Boehringer Ingelheim Parkinson's Disease Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Impax
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Parkinson's Disease Product Category, Application and Specification
3.7.3 Impax Parkinson's Disease Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Lundbeck
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Parkinson's Disease Product Category, Application and Specification
3.8.3 Lundbeck Parkinson's Disease Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Sun Pharma
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Parkinson's Disease Product Category, Application and Specification
3.9.3 Sun Pharma Parkinson's Disease Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Wockhardt
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Parkinson's Disease Product Category, Application and Specification
3.10.3 Wockhardt Parkinson's Disease Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
3.11 UCB
3.12 Valeant Pharmaceuticals
3.13 Acadia
4 Parkinson's Disease Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Parkinson's Disease Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Parkinson's Disease Sales and Revenue by Regions
4.2.1 Global Parkinson's Disease Sales and Market Share by Regions (2014-2019)
4.2.2 Global Parkinson's Disease Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Parkinson's Disease Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Parkinson's Disease Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Parkinson's Disease Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Parkinson's Disease Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Parkinson's Disease Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Parkinson's Disease Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Parkinson's Disease Application/End Users
5.1 Parkinson's Disease Segment by Application
5.1.1 Hospitals
5.1.2 Clinics
5.2 Global Parkinson's Disease Product Segment by Application
5.2.1 Global Parkinson's Disease Sales by Application
5.2.2 Global Parkinson's Disease Sales and Market Share by Application (2014-2019)
6 Global Parkinson's Disease Market Forecast
6.1 Global Parkinson's Disease Sales, Revenue Forecast (2019-2025)
6.1.1 Global Parkinson's Disease Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Parkinson's Disease Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Parkinson's Disease Forecast by Regions
6.2.1 North America Parkinson's Disease Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Parkinson's Disease Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Parkinson's Disease Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Parkinson's Disease Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Parkinson's Disease Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Parkinson's Disease Forecast by Type
6.3.1 Global Parkinson's Disease Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Carbidopa/Levodopa Gowth Forecast
6.3.3 Dopamine Receptor Agonists Gowth Forecast
6.4 Parkinson's Disease Forecast by Application
6.4.1 Global Parkinson's Disease Sales Forecast by Application (2019-2025)
6.4.2 Global Parkinson's Disease Forecast in Hospitals
6.4.3 Global Parkinson's Disease Forecast in Clinics
7 Parkinson's Disease Upstream Raw Materials
7.1 Parkinson's Disease Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Parkinson's Disease Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
